A cost-effectiveness analysis of okt3 induction therapy in cadaveric kidney transplantation
- 1 June 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (6) , 855-864
- https://doi.org/10.1016/s0272-6386(96)90524-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipientsPublished by American Medical Association (AMA) ,1993
- THE EFFECTS OF INTRAOPERATIVE ADMINISTRATION OF OKT3 DURING RENAL TRANSPLANTATIONTransplantation, 1993
- THE LONG-TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY TRANSPLANTATION—A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED STUDYTransplantation, 1992
- The Medicare End-Stage Renal Disease ProgramNew England Journal of Medicine, 1991
- Effect of Transplantation on the Medicare End-Stage Renal Disease ProgramNew England Journal of Medicine, 1988
- Cost-Effectiveness Analysis of TransplantationSurgical Clinics of North America, 1986
- The Quality of Life of Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1985
- The quality of life of hemodialysis and transplant patientsKidney International, 1982
- Analysis of costs and outcomes of renal transplantation at one center. Its implicationsPublished by American Medical Association (AMA) ,1979
- Predicting Treatment Costs and Life Expectancy for End-Stage Renal DiseaseNew England Journal of Medicine, 1978